<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180603039966N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-12</date_registration>
      <primary_sponsor>Gorgan University of Medical Sciences</primary_sponsor>
      <public_title>ANH effect on hemodynamic and blood transfusion rate in CABG patients</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of Acute Normovolemic Hemodilution(ANH) on hemodynamics and blood transfusion rate in patients undergoing on-pump CABG</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>172</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57740</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Based on the table of random numbers, a column is randomly selected and choose the right side column, If the last digit of the number selected is the same as the patient's last digit case number, the patient will be in the intervention group, and otherwise in the control group, Blinding description: The professor does all the procedures and the data is recorded by the anesthesia technician. The data analyzer does the analysis based on groups A and B. The patient is anesthetized during the entire surgery and procedure and unaware of the study groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Patients undergoing On-Pump CABG.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients who are admitted to Amir-al-Momenin hospital in Kordkoy and Baqiyatallah hospital in Tehran for elective CABG who undergoes Acute Normovolemic Hemodilution. Every 1cc of blood taken from the patient's arterial catheter is compensated with 3cc of intravenous normal saline, the parameters are measured, and the stored blood is injected into the patient at the end of the surgery. Intervention 2: Control group: Intervention group: Patients who are admitted to Amir-al-Momenin hospital in Kordkoy and Baqiyatallah hospital in Tehran for elective CABG who does not undergo Acute Normovolemic Hemodilution. In these patients, an arterial catheter is routinely inserted and hemodynamic parameters are also recorded.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amirali Jabbari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shast-kola Road, Hirkan blvd</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4934174515</zip>
        <telephone>+98 17 3245 2651</telephone>
        <email>dr.a.jabbari@gmail.com</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amirali Jabbari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shast-kola Road, Hirkan blvd</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4934174515</zip>
        <telephone>+98 17 3245 2651</telephone>
        <email>dr.a.jabbari@gmail.com</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>CABG candidates with hemoglubin level above 14 g/dL
CABG candidates with left Ventricular Ejection Fraction above 35%</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients refusal to participate
History of cerebrovascular accident(ischemic or hemorrhagic)
History of carotid stenosis
History of ischemia or active bleeding(GI bleeding, mesenteric ischemia, claudication)
History of renal failure
History of liver failure</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I25.70</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients who are admitted to Amir-al-Momenin hospital in Kordkoy and Baqiyatallah hospital in Tehran for elective CABG who undergoes Acute Normovolemic Hemodilution. Every 1cc of blood taken from the patient's arterial catheter is compensated with 3cc of intravenous normal saline, the parameters are measured, and the stored blood is injected into the patient at the end of the surgery.</i_keyword>
      <i_keyword>Control group: Intervention group: Patients who are admitted to Amir-al-Momenin hospital in Kordkoy and Baqiyatallah hospital in Tehran for elective CABG who does not undergo Acute Normovolemic Hemodilution. In these patients, an arterial catheter is routinely inserted and hemodynamic parameters are also recorded.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Need for blood transfusion. Timepoint: Will be recorded during surgery and until the discharge from the ICU. Method of measurement: Number of packed cell transfused.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Mean Arterial Pressire(MAP). Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: Transducer via Arterial line catheter.</sec_outcome>
      <sec_outcome>Systolic Blood Pressure(SBP). Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: Transducer via Arterial line catheter.</sec_outcome>
      <sec_outcome>Diastolic Blood Pressure(DBP). Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: Transducer via Arterial line catheter.</sec_outcome>
      <sec_outcome>Urine Output(U/O). Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: Urinary drainage Bag.</sec_outcome>
      <sec_outcome>Central Vein Pressure. Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: CVP Manometer set.</sec_outcome>
      <sec_outcome>Arterial Blood PH. Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: ABG Analyzer.</sec_outcome>
      <sec_outcome>Partial pressure of oxygen(Pao2). Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: ABG Analyzer.</sec_outcome>
      <sec_outcome>Partial pressure of carbon dioxide (PaCO2). Timepoint: Will be recorded during surgery and also at 0, 6, 12, 24 hours after the surgery, And if necessary, will be assessed PRN. Method of measurement: ABG Analyzer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gorgan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-31</approval_date>
        <contact_name>Glestan Medical University Ethics Committee</contact_name>
        <contact_address>shastkola road Gorgan Golestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
